“Baricitinib Achieved Complete/Near Complete Scalp Coverage in SALT Score ≤20 Responders: 52-Week Findings From BRAVE-AA Trials”, J of Skin, vol. 9, no. 1, p. s520, Jan. 2025, doi: 10.25251/skin.9.supp.520.